GEODE CAPITAL MANAGEMENT, LLC

Position in PLX — Protalix BioTherapeutics, Inc.

CIK 1214717 BOSTON, MA

Position in PLX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$2,283,388

+$405,692 QoQ

Shares Held

979,995

+13.3% QoQ

Ownership

1.22%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 101 holders

Holding Since

Jun 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. PLX ranks #288 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,017,848	$2,989,245,636
2	REGN	Regeneron Pharmaceuticals, Inc.	2,625,810	$1,637,297,566
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,635,840	$793,466,914
4	RVMD	Revolution Medicines, Inc.	3,942,676	$738,384,360
5	MRNA	Moderna, Inc.	9,710,335	$680,014,759
6	INCY	Incyte Corp	4,750,735	$538,543,319
7	RPRX	Royalty Pharma plc	8,058,048	$451,814,751
8	INSM	INSMED Inc	4,220,155	$449,952,925

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,283,388	979,995	+13.3%	Shares	Defined	2026-08-12
2026-03-31	$1,877,696	865,298	+4.2%	Shares	Defined	2026-05-15
2025-12-31	$1,494,096	830,054	+1.3%	Shares	Defined	2026-02-09
2025-09-30	$1,819,904	819,777	-0.8%	Shares	Defined	2025-11-12
2025-06-30	$1,222,972	826,333	+9.6%	Shares	Defined	2025-08-08
2024-03-31	$950,178	754,110	+4.1%	Shares	Defined	2024-05-13
2023-12-31	$1,289,743	724,575	+3.5%	Shares	Defined	2024-02-13
2023-09-30	$1,162,350	700,211	+26.8%	Shares	Defined	2023-11-13
2023-06-30	$1,104,742	552,371	—	Shares	Defined	2023-08-11
No filing history on record for this holder in this stock.